Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 551–566 of 566 matching trials (filtered from 7,816) · page 23 of 23, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND) NCT05565833 SHUTi OASIS; Patient Education Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 144 | University of Virginia OTHER |
2024-05-08 |
|
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase NCT05820919 LOCK Sleep Program; No intervention (control period/baseline data c... Runs in: United States · 3 sites |
NA other |
RECRUITING | 456 | University of Alabama, Tuscaloosa OTHER |
2024-03-12 |
|
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort NCT01574053 Runs in: Argentina; Australia; Austria; Belgium; Canada; Chile; Co... · 183 sites |
NA other |
RECRUITING | 35,000 | CHDI Foundation, Inc. OTHER |
2024-02-28 |
|
Revealing Engagement Dynamics Among Semantic Dementia Patients NCT06218732 Runs in: United States · 1 site |
NA other |
NOT_YET_RECRUITING | 500 | Power Life Sciences Inc. INDUSTRY |
2024-01-23 |
|
Navigating the Clinical Research Process for Mild Cognitive Impairment NCT06207903 Runs in: United States · 1 site |
NA other |
NOT_YET_RECRUITING | 500 | Power Life Sciences Inc. INDUSTRY |
2024-01-17 |
|
Alzheimer's National Registry for Treatment and Diagnostics(ALZ-NET) NCT06170268 Routine Care Documentation Runs in: United States · 1 site |
NA other |
RECRUITING | 20,000 | Alzheimer's Disease and Related Disorders Association, Inc OTHER |
2023-12-14 |
|
Triage Survey for Neurology Research Eligibility NCT06104852 Survey; Optional Medication Washout Runs in: United States · 3 sites |
NA other |
RECRUITING | 600 | Adams Clinical NETWORK |
2023-10-27 |
|
Gamma-Music Based Intervention for Mild Alzheimer's Disease NCT05984524 Gamma-Music Based Intervention Runs in: United States · 1 site |
NA other |
RECRUITING | 60 | Northeastern University OTHER |
2023-10-06 |
|
Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study NCT06058234 Monoclonal Antibodies Directed Against Amyloid for the Treatment of... Runs in: United States · 1 site |
NA other |
RECRUITING | 8,680 | Centers for Medicare and Medicaid Services/ Coverage and Analysis Group OTHER_GOV |
2023-09-28 |
|
Light and Sleep Fragmentation NCT06009289 Light therapy Runs in: United States · 1 site |
PHASE4 other |
NOT_YET_RECRUITING | 120 | Stanford University OTHER |
2023-08-25 |
|
Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease NCT04436081 THC-free CBD Oil; Placebo Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 40 | Eastern Virginia Medical School OTHER |
2023-02-16 |
|
Phase I Human Analytics (HALO) Study NCT05423860 no interventions will be performed (observational) Runs in: United States · 1 site |
NA other |
RECRUITING | 2,000 | HALO Diagnostics INDUSTRY |
2022-10-14 |
|
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease NCT03082755 Gabapentin Enacarbil; Placebo Oral Tablet Runs in: United States · 1 site |
PHASE4 other |
RECRUITING | 156 | University of Texas at Austin OTHER |
2022-05-18 |
|
Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions NCT04684602 PrimePro™/ PrimeMSK™ Runs in: United States · 1 site |
PHASE1|PHASE2 other |
RECRUITING | 5,000 | Thomas Advanced Medical LLC INDUSTRY |
2022-04-29 |
|
Modifiable Variables in Parkinsonism (MVP) NCT02194816 Runs in: United States · 1 site |
NA other |
RECRUITING | 2,000 | Bastyr University OTHER |
2022-03-25 |
|
DC Longitudinal Study on Aging and Specimen Bank NCT03702907 Runs in: United States · 1 site |
NA other |
RECRUITING | 1,000 | Georgetown University OTHER |
2019-10-24 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
Last updated
From the research library
The highest-scoring studies we hold on this subject, each summarized in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial